US Stock MarketDetailed Quotes
KTRA Kintara Therapeutics
- 0.2154
- 0.00000.00%
Close Oct 17 16:00 ET
11.99MMarket Cap-673P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.2154Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)55.66MShares23.730052wk High-1.84P/B11.97MFloat Cap2.835052wk Low--Dividend TTM55.59MShs Float238000.0000Historical High--Div YieldTTM0.00%Amplitude2.8350Historical Low--Avg Price1Lot Size
Kintara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 219.80%4.91M | 219.80%4.91M | 108.57%6.35M | -86.50%658K | -96.95%216K | -86.97%1.54M | -86.97%1.54M | -65.55%3.05M | -65.34%4.87M | -63.36%7.09M |
| -Cash and cash equivalents | 219.80%4.91M | 219.80%4.91M | 108.57%6.35M | -86.50%658K | -96.95%216K | -86.97%1.54M | -86.97%1.54M | -65.55%3.05M | -65.34%4.87M | -63.36%7.09M |
| Receivables | ---- | ---- | --208K | -61.63%414K | ---- | ---- | ---- | ---- | 15.52%1.08M | 39.27%1.07M |
| -Accounts receivable | ---- | ---- | ---- | --103K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Taxes receivable | ---- | ---- | ---- | --311K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivables | ---- | ---- | --208K | ---- | ---- | ---- | ---- | ---- | 15.52%1.08M | 39.27%1.07M |
| Prepaid assets | -80.93%205K | -80.93%205K | -90.88%196K | -96.47%114K | --0 | --1.08M | --1.08M | --2.15M | --3.23M | ---- |
| Other current assets | -37.27%414K | -37.27%414K | ---- | ---- | --567K | --660K | --660K | --821K | ---- | ---- |
| Total current assets | 69.05%5.53M | 69.05%5.53M | 12.28%6.76M | -87.08%1.19M | -90.40%783K | -75.34%3.27M | -75.34%3.27M | -40.39%6.02M | -38.81%9.18M | -59.44%8.16M |
| Non current assets | ||||||||||
| Net PPE | -4.94%674K | -4.94%674K | -4.56%691K | -5.41%699K | -7.96%694K | 687.78%709K | 687.78%709K | 589.52%724K | 515.83%739K | 458.52%754K |
| Non current prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | 104.76%4.3M |
| Total non current assets | -4.94%674K | -4.94%674K | -4.56%691K | -5.41%699K | -86.27%694K | -73.64%709K | -73.64%709K | -73.23%724K | -72.83%739K | 126.13%5.05M |
| Total assets | 55.87%6.2M | 55.87%6.2M | 10.47%7.45M | -80.99%1.89M | -88.82%1.48M | -75.05%3.98M | -75.05%3.98M | -47.34%6.74M | -44.03%9.92M | -40.88%13.21M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -26.70%2.26M | -26.70%2.26M | -51.94%1.34M | -42.27%1.87M | -5.12%3.34M | -22.76%3.08M | -22.76%3.08M | -13.89%2.79M | -5.79%3.24M | 17.16%3.52M |
| -accounts payable | -20.73%2.21M | -20.73%2.21M | -52.38%1.24M | -36.01%1.72M | 1.87%3M | -14.84%2.78M | -14.84%2.78M | -6.18%2.61M | -7.05%2.69M | 17.25%2.94M |
| -Due to related parties current | -82.55%52K | -82.55%52K | -45.56%98K | -72.99%148K | -41.01%338K | -58.67%298K | -58.67%298K | -60.70%180K | 0.92%548K | 16.70%573K |
| Current liabilities | -26.70%2.26M | -26.70%2.26M | -51.94%1.34M | -42.27%1.87M | -5.12%3.34M | -22.76%3.08M | -22.76%3.08M | -13.89%2.79M | -5.79%3.24M | 17.16%3.52M |
| Non current liabilities | ||||||||||
| Other non current liabilities | 12.05%186K | 12.05%186K | 11.59%183K | 123.75%179K | 119.74%167K | 1.84%166K | 1.84%166K | -4.65%164K | -55.06%80K | -57.54%76K |
| Total non current liabilities | 12.05%186K | 12.05%186K | 11.59%183K | 123.75%179K | 119.74%167K | 1.84%166K | 1.84%166K | -4.65%164K | -55.06%80K | -57.54%76K |
| Total liabilities | -24.72%2.45M | -24.72%2.45M | -48.41%1.52M | -38.26%2.05M | -2.48%3.5M | -21.79%3.25M | -21.79%3.25M | -13.42%2.95M | -8.21%3.32M | 12.96%3.59M |
| Shareholders'equity | ||||||||||
| Share capital | -3.19%10.31M | -3.19%10.31M | -3.19%10.31M | -4.79%10.26M | -16.03%10.61M | -15.20%10.65M | -15.20%10.65M | -15.52%10.65M | -16.12%10.78M | -7.93%12.64M |
| -common stock | 2,650.00%55K | 2,650.00%55K | 2,650.00%55K | 400.00%10K | -97.53%2K | 100.00%2K | 100.00%2K | -95.92%2K | -95.92%2K | 68.75%81K |
| -Preferred stock | -3.69%10.25M | -3.69%10.25M | -3.69%10.25M | -4.86%10.25M | -15.50%10.61M | -15.21%10.65M | -15.21%10.65M | -15.21%10.65M | -15.82%10.78M | -8.20%12.55M |
| Retained earnings | -5.62%-159.88M | -5.62%-159.88M | -6.43%-157.55M | -7.44%-155.54M | -9.34%-154.51M | -11.01%-151.38M | -11.01%-151.38M | -13.09%-148.04M | -15.31%-144.77M | -18.10%-141.32M |
| Paid-in capital | 8.39%153.31M | 8.39%153.31M | 8.49%153.14M | 3.21%145.09M | 2.59%141.86M | 4.32%141.44M | 4.32%141.44M | 10.56%141.16M | 10.88%140.57M | 10.56%138.28M |
| Gains losses not affecting retained earnings | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K | 0.00%21K |
| Total stockholders'equity | 413.95%3.76M | 413.95%3.76M | 56.42%5.92M | -102.49%-164K | -121.06%-2.03M | -93.80%731K | -93.80%731K | -59.66%3.79M | -53.21%6.6M | -49.81%9.62M |
| Total equity | 413.95%3.76M | 413.95%3.76M | 56.42%5.92M | -102.49%-164K | -121.06%-2.03M | -93.80%731K | -93.80%731K | -59.66%3.79M | -53.21%6.6M | -49.81%9.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data